8R7G

Crystal structure of the kinase domain of ACVR1 (ALK2) with M4K2234

Summary for 8R7G

Entry DOI	10.2210/pdb8r7g/pdb
Descriptor	Activin receptor type I, 2-fluoranyl-6-methoxy-4-[4-methyl-5-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]pyridin-3-yl]benzamide (3 entities in total)
Functional Keywords	alk2, acvr1, kinase, inhibitor, m4k2234, signaling protein
Biological source	Homo sapiens (human)
Total number of polymer chains	4
Total formula weight	140000.77
Authors	Williams, E.P.,Cros, J.,Ensan, D.,Smil, D.,Edwards, A.M.,O'Meara, J.A.,Fernandez-Cid, A.,Isaac, M.B.,Al-awar, R.,Bullock, A.N. (deposition date: 2023-11-24, release date: 2024-04-03)
Primary citation	Ensan, D.,Smil, D.,Zepeda-Velazquez, C.A.,Panagopoulos, D.,Wong, J.F.,Williams, E.P.,Adamson, R.,Bullock, A.N.,Kiyota, T.,Aman, A.,Roberts, O.G.,Edwards, A.M.,O'Meara, J.A.,Isaac, M.B.,Al-Awar, R. Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma. J.Med.Chem., 63:4978-4996, 2020 Cited by PubMed: 32369358 DOI: 10.1021/acs.jmedchem.0c00395 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.09 Å)

Structure validation